Biohaven Therapeutics Ltd.

This study tested a new medication called BHV-2100 to see if it can safely and quickly stop migraine pain and other symptoms like nausea or sensitivity to light. About 647 people with migraines took either the drug or a placebo. The main goal was to see how many were pain-free an…

This study looked at the long-term safety of the drug BHV-7000 in 233 adults with major depressive disorder. Participants had already completed an earlier study. The main goal was to track serious side effects and other health changes. The study did not test how well the drug wor…

This study tested a new medication called BHV-7000 in 336 adults with moderate to severe major depression. Participants stopped their usual antidepressants and took either the study drug or a placebo for 6 weeks. The main goal was to see if BHV-7000 reduces depression symptoms be…

This study tested a new drug, BHV-7000, to see if it can safely and effectively reduce manic symptoms in people with bipolar I disorder. The trial involved 274 adults hospitalized for a manic episode. Researchers measured changes in mania severity over 21 days using a standard ra…